In contrast, the BRAF mutation has not been associated with the most invasive and metastatic disease in children with PTC; therefore, more data are needed to understand the natural history of BRAF-driven PTC in this population [8,19,20,21]. This evidence concerns the gene BRAF and metastatic neoplasm.